Materialise NV P/E ratio

P/E ratio of MTLS for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/E ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its earnings per share. A low P/E ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. P/E ratio can be compared to different companies in the same industry or to a company’s own historical valuation.

Highlights and Quick Summary

Current P/E ratio of Materialise NV is 0.0 (as of December 30, 2020)
  • P/E ratio for the quarter ending June 29, 2021 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly P/E ratio decreased by NaN%
  • Annual P/E ratio for 2020 was 0.0 (a -100.0% decrease from previous year)
  • Annual P/E ratio for 2019 was 610.33 (a 113.3% increase from previous year)
  • Annual P/E ratio for 2018 was 286.14 (a Infinity% increase from previous year)
Visit stockrow.com/MTLS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/E ratio of Materialise NV

Most recent P/E ratioof MTLS including historical data for past 10 years.

Interactive Chart of P/E ratio of Materialise NV

Materialise NV P/E ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 0.0 0.0 – – –
2020 0.0 0.0 0.0 0.0 0.0
2019 610.33 1848.0 471.0 261.67 610.33
2018 286.14 137.5 1279.0 0.0 286.14
2017 0.0 0.0 0.0 0.0 0.0
2016 0.0 0.0 0.0 0.0 0.0
2015 0.0 0.0 0.0 233.0 0.0
2014 238.0 124.78 164.29 105.0 238.0
2013 105.0 105.0 105.0 – 105.0

Business Profile of Materialise NV

Sector: Technology
Industry: Software—Application
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. It operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
© stockrow.com